Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 05, 2022 16:58 ET | Source: Hagens Berman Sobol Shapiro LLP

ABT DEADLINE ALERT: Hagens Berman, National Trial Attorneys, Encourages Abbott Laboratories (ABT) Investors with Significant Losses to Contact Firm’s Attorneys, Securities Fraud Class Action Pending

SAN FRANCISCO, Oct. 05, 2022 (GLOBE NEWSWIRE) -- Hagens Berman urges Abbott Laboratories (NYSE: ABT) investors who suffered significant losses to submit your losses now. Class Period: Feb. 19, 2021...
September 27, 2022 14:01 ET | Source: Hagens Berman Sobol Shapiro LLP

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Abbott Laboratories (ABT) Investors with Significant Losses to Contact Firm’s Attorneys, Securities Fraud Class Action Pending

SAN FRANCISCO, Sept. 27, 2022 (GLOBE NEWSWIRE) -- Hagens Berman urges Abbott Laboratories (NYSE: ABT) investors who suffered significant losses to submit your losses now. Class Period: Feb. 19,...
September 22, 2022 13:08 ET | Source: Hagens Berman Sobol Shapiro LLP

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Abbott Laboratories (ABT) Investors with Significant Losses to Contact Firm’s Attorneys, Deadline Approaching in Securities Fraud Class Action

SAN FRANCISCO, Sept. 22, 2022 (GLOBE NEWSWIRE) -- Hagens Berman urges Abbott Laboratories (NYSE: ABT) investors who suffered significant losses to submit your losses now. Class Period: Feb. 19,...
September 17, 2022 12:10 ET | Source: Hagens Berman Sobol Shapiro LLP

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Abbott Laboratories (ABT) Investors with Significant Losses to Contact Firm’s Attorneys, Securities Fraud Class Action Filed

SAN FRANCISCO, Sept. 17, 2022 (GLOBE NEWSWIRE) -- Hagens Berman urges Abbott Laboratories (NYSE: ABT) investors who suffered significant losses to submit your losses now. Class Period: Feb. 19,...
September 12, 2022 10:33 ET | Source: Hagens Berman Sobol Shapiro LLP

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Abbott Laboratories (ABT) Investors with Significant Losses to Contact Firm’s Attorneys, Securities Fraud Class Action Filed

SAN FRANCISCO, Sept. 12, 2022 (GLOBE NEWSWIRE) -- Hagens Berman urges Abbott Laboratories (NYSE: ABT) investors who suffered significant losses to submit your losses now. Class Period: Feb. 19, 2021...
September 07, 2022 18:42 ET | Source: Hagens Berman Sobol Shapiro LLP

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Abbott Laboratories (ABT) Investors with Significant Losses to Contact Firm’s Attorneys, Infant Formula-Related Securities Fraud Class Action Filed

SAN FRANCISCO, Sept. 07, 2022 (GLOBE NEWSWIRE) -- Hagens Berman urges Abbott Laboratories (NYSE: ABT) investors who suffered significant losses to submit your losses now. Class Period: Feb....
September 02, 2022 18:46 ET | Source: Hagens Berman Sobol Shapiro LLP

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Abbott Laboratories (ABT) Investors with Significant Losses to Contact Firm’s Attorneys, Infant Formula-Related Securities Fraud Class Action Filed

SAN FRANCISCO, Sept. 02, 2022 (GLOBE NEWSWIRE) -- Hagens Berman urges Abbott Laboratories (NYSE: ABT) investors who suffered significant losses to submit your losses now. Class Period: Feb. 19,...